Showing 1 - 20 results of 35 for search 'Hans-Jürgen Wester', query time: 0.08s
Refine Results
-
1
-
2
Integration of DOTA as a bridging unit during solid-phase peptide synthesis by Lennard Wendlinger, Mara Parzinger, Margret Schottelius, Hans-Jürgen Wester
Published 2023-12-01
Article -
3
-
4
-
5
-
6
-
7
-
8
Development of the First <sup>18</sup>F-Labeled Radiohybrid-Based Minigastrin Derivative with High Target Affinity and Tumor Accumulation by Substitution of the Chelating Moiety by Thomas Günther, Nadine Holzleitner, Daniel Di Carlo, Nicole Urtz-Urban, Constantin Lapa, Hans-Jürgen Wester
Published 2023-03-01
Article -
9
Significant reduction of activity retention in the kidneys via optimized linker sequences in radiohybrid-based minigastrin analogs by Nadine Holzleitner, Sebastian Fischer, Isabel Maniyankerikalam, Roswitha Beck, Constantin Lapa, Hans-Jürgen Wester, Thomas Günther
Published 2024-03-01
Article -
10
Synthesis of Symmetrical Tetrameric Conjugates of the Radiolanthanide Chelator DOTPI for Application in Endoradiotherapy by Means of Click Chemistry by Alexander Wurzer, Adrienn Vágner, Dávid Horváth, Flóra Fellegi, Hans-Jürgen Wester, Ferenc K. Kálmán, Johannes Notni
Published 2018-04-01
Article -
11
-
12
-
13
Theranostic Value of Multimers: Lessons Learned from Trimerization of Neurotensin Receptor Ligands and Other Targeting Vectors by Simone Maschauer, Jürgen Einsiedel, Dominik Reich, Harald Hübner, Peter Gmeiner, Hans-Jürgen Wester, Olaf Prante, Johannes Notni
Published 2017-03-01
Article -
14
The Influence of the Combination of Carboxylate and Phosphinate Pendant Arms in 1,4,7-Triazacyclononane-Based Chelators on Their 68Ga Labelling Properties by Gábor Máté, Jakub Šimeček, Miroslav Pniok, István Kertész, Johannes Notni, Hans-Jürgen Wester, László Galuska, Petr Hermann
Published 2015-07-01
Article -
15
Optimization of the Pharmacokinetic Profile of [<sup>99m</sup>Tc]Tc-N<sub>4</sub>-Bombesin Derivatives by Modification of the Pharmacophoric Gln-Trp Sequence by Thomas Günther, Matthias Konrad, León Stopper, Jan-Philip Kunert, Sebastian Fischer, Roswitha Beck, Angela Casini, Hans-Jürgen Wester
Published 2022-09-01
Article -
16
-
17
Synthesis and preclinical evaluation of novel 18F-labeled Glu-urea-Glu-based PSMA inhibitors for prostate cancer imaging: a comparison with 18F-DCFPyl and 18F-PSMA-1007 by Stephanie Robu, Alexander Schmidt, Matthias Eiber, Margret Schottelius, Thomas Günther, Behrooz Hooshyar Yousefi, Markus Schwaiger, Hans-Jürgen Wester
Published 2018-04-01
Article -
18
Equilibrium Thermodynamics, Formation, and Dissociation Kinetics of Trivalent Iron and Gallium Complexes of Triazacyclononane-Triphosphinate (TRAP) Chelators: Unraveling the Founda... by Adrienn Vágner, Attila Forgács, Ernő Brücher, Imre Tóth, Alessandro Maiocchi, Alexander Wurzer, Hans-Jürgen Wester, Johannes Notni, Zsolt Baranyai, Zsolt Baranyai
Published 2018-05-01
Article -
19
-
20
Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies by Alexander Wurzer, Francesco De Rose, Sebastian Fischer, Markus Schwaiger, Wolfgang Weber, Stephan Nekolla, Hans-Jürgen Wester, Matthias Eiber, Calogero D’Alessandria
Published 2024-02-01
Article